Leveraging AI within eBV to optimize speed to therapy

What approach to electronic benefit verification (eBV) is the right solution for now and into the future? eBV technology has changed. While logic-based approaches still have their place, AI has opened up a path to improved access for patients and added benefits for all stakeholders. For manufacturers, working with a patient service provider that blends compassionate human expertise with technology-based resources offers the best chance of optimizing speed to therapy in the increasingly complex and collaborative pharma ecosystem.

Join Lash Group’s Myra Reinhardt, VP, Product Innovation and Analytics, and Shanna Barnes, VP, New Business Development, as they share their extensive knowledge of access solutions and patient support.

__

WEDNESDAY, APRIL 29 | 12:00 PM EDT

In Part one you’ll:
-Gain information on the technology and approach that help accelerates speed to therapy
-Identify drivers that impact eBV effectiveness

MONDAY, MAY 18 | 1:00 PM EDT

In Part two you’ll:
-Gain actionable tips for vetting medical and pharmacy BV solutions
-Learn when and how to move to the next step in activating access solutions for your program